429 related articles for article (PubMed ID: 8200939)
21. Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease.
Cannavò S; Li Calzi L; Aragona A; Trimarchi F
J Endocrinol Invest; 1988 Jun; 11(6):425-8. PubMed ID: 2850311
[TBL] [Abstract][Full Text] [Related]
22. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
23. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
[TBL] [Abstract][Full Text] [Related]
24. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
Pecori Giraldi F; Invitti C; Cavagnini F;
Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
26. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
Westendorf JM; Schonbrunn A
Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
[TBL] [Abstract][Full Text] [Related]
27. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
29. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
30. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
31. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
32. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
Schteingart DE; McKenzie AK
J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
[TBL] [Abstract][Full Text] [Related]
33. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
[TBL] [Abstract][Full Text] [Related]
34. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
[TBL] [Abstract][Full Text] [Related]
35. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
[TBL] [Abstract][Full Text] [Related]
36. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
[TBL] [Abstract][Full Text] [Related]
37. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
38. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
39. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
40. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
